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Abstract
Background: Cyclophilin A (CyPA), a ubiquitously distributed intracellular protein, is thought to be one of the
important inflammatory factors and plays a significant role in the development process of sepsis. In the form of
cytokine, CyPA deteriorates sepsis by promoting intercellular communication, apoptosis of endothelial cells and
chemotactic effect on inflammatory cells. In our previous study, cyclophilin A of Clonorchis sinensis (CsCyPA), a type
of excretory-secretory antigen, could induce the patients infected with Clonorchis sinensis to produce specific
anti-CsCyPA antibodies. In this study, we investigated whether anti-CsCyPA antibodies could cross-react with CyPA
and then play a protective role against sepsis, just like other anti-cytokine antagonists.
Methods: The mice model with sepsis was established with cecal ligation and puncture (CLP). Fifty mg/kg purified
anti-CsCyPA antibodies were injected via the caudal vein 6 h after the CLP operation, and persistent observation
was performed for 72 h. Blood samples and tissues were collected at 6 h, 12 h, 24 h, 48 h and 72 h after CLP.
Cytokines in serum were measured by ELISA. Lung and mesentery tissues were stained with hematoxylin-eosin.
Endothelial cells (ECs) isolated from murine aorta were co-cultured with CyPA of mice (MuCyPA) and anti-CsCyPAs
for 24 h, then, viability was measured by Cell Counting Kit-8.
Results: Anti-CsCyPA antibodies could combine with MuCyPA and inhibite its peptidyl prolyl isomerase (PPIase)
activity. In the antibodies treatment group, blood coagulation indicators including PT, aPTT, D-dimer and platelet
count were obviously more ameliorative, the proinflammary factors like IL-6, TNF-α, IL-1β were significantly lower at
12 h and 24 h after surgery and the viability of ECs was significantly improved compared to those in the control
group. Furthermore, the survival rate was elevated, ranging from 10.0 % to 45.0 % compared to the control group.
Conclusions: These antibodies may have a favorable effect on sepsis via inhibition of enzymic activity or protection
of endothelial cells.
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Background
Sepsis is defined as a systemic inflammatory response
syndrome (SIRS) coupled with a documented infection
that may result in septic shock and multiple organ fail-
ure (MOF) [1]. The sepsis mortality in humans has been
high at more than 50 % [2]. SIRS serves as a hallmark
sign of sepsis, and is characterized by a hyperinflamma-
tory response of the host to invading pathogens that are
primarily mediated by cytokines [3]. However, treatment
of patients suffering from sepsis with traditional proin-
flammatory cytokine antagonist, such as anti-TNF-α,
interleukin-1 receptor antagonist, bradykinin antagonist
and others, did not prove effective in controlling multi-
organ damage and mortality [4].
Cyclophilins (CyPs) are a family of ubiquitous proteins
evolutionarily well conserved and present in all prokary-
otes and eukaryotes [5]. Equipped with PPIase activity,
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CyPs catalyze the isomerization of peptide bonds from the
trans form to cis form at proline residues and facilitate
protein folding [6]. Cyclophilin A (CyPA), a universally
expressed protein belonging to the CyPs family, can be se-
creted from cells in response to inflammatory stimuli such
as hypoxia, infection, sepsis and oxidative stress [7–10]. In
the form of cytokine, CyPA deteriorates sepsis by promot-
ing intercellular communication, apoptosis of endothelial
cells and chemotactic effect on inflammatory cells [11].
Clonorchis sinensis (C. sinensis), causing clonorchiasis,
has been one of the most important food-borne parasites in
China [12]. Most people infected with C.sinensis present no
apparent clinical manifestations. Only 5 %–10 % of infected
people have non-specific symptoms such as abdominal pain
in the right upper quadrant, flatulence, and fatigue [13, 14].
A C.sinensis adult full-length complementary DNA (cDNA)
plasmid library was established in our laboratory in 2004
[15]. CsCyPA was found to be an excretory protein and able
to induce high anti-CsCyPA antibodies (anti-CsCyPAs) ti-
ters in patients infected with C.sinensis in our previous
study [16].
In 1989, David P Strachan proposed a hygiene hypoth-
esis, according to which the decreased incidence of infec-
tions with parasites in developed countries may be the
underlying cause for some diseases [17, 18]. Nowadays,
parasites and their products constitute the targets of stud-
ies as a potential alternative approach for parasitic, viral,
bacterial, and autoimmune diseases [19–21]. Therefore,
the aim of this study was to determine whether anti-
CsCyPAs could, like other anti-cytokine antagonists, play
a protective role against sepsis.
Methods
Preparation of recombinant CyPA and polyclonal antibodies
Recombinant CsCyPA (rCsCyPA) was produced in a pre-
vious study [16]. Furthermore, recombinant CyPA of
Schistosoma japonicum (rSjCyPA), mouse (rMuCyPA) and
human (rHsCyPA) were produced using the same process.
Six SD rats were divided randomly into two groups, one
group was injected subcutaneously with 100 μg rCsCyPA
emulsified with equal volume of complete Freund’s adju-
vant (CFA, Sigma), followed by three boosts with 50 μg
antigen emulsified with incomplete Freund’s adjuvant
(IFA, Sigma) at 2-week intervals. The other group was im-
munized with PBS as control. Two weeks after the last
vaccination, serum samples were collected from the mice
and the rCsCyPA-specific IgG detected by ELISA.
Antisera were precipitated three times with ammonium
sulphate (33 % saturation), the pellet dissolved in TBS buf-
fer (20 mM Tris–HCl, pH 7.5, 0.15 M NaCl) and dialyzed
against the same buffer for 18 h. Antibodies were purified
by affinity chromatography on a G-Sepharose column.
Antibodies were eluted from the column with 0.1 M
glycine-HCl, pH8.8, and then, dialyzed against TBS solu-
tion for 18 h. The concentration of anti-CsCyPAs was
measured by using a BCA Protein Assay Kit (Thermo,
USA) following the manufacturer’s instructions.
Identification by Western blot analysis
The purified rCsCyPAs, rSjCyPA, rMuCyPA and rHsCyPA
(25 ug of each protein) were subjected to SDS-PAGE
(12 %). After electrotransferral to a polyvinylidene difluor-
ide (PVDF) membrane (Whatman), the blotted membranes
were probed with anti-CsCyPAs or PBS and subsequently
incubated with horseradish peroxidase (HRP)-conjugated
goat anti-rat secondary antibody (Santa Cruz). Finally, the
result was visualized using diaminobenziine (DAB, Boster,
Wuhan, China) substrate solution.
PPIase activity and inhibition
Colorimetric detection of PPIase activity was performed
by the chymotrypsin-coupledcleavage assay according to
Fischer et al. [22]. Briefly, 10 ug of rMuCyPA per reaction
system was co-cultured with 1 ug or 10 ug anti-CsCyPAs
for 1 h at 37 °C before experiment. The enzymatic activity
was performed in 50 mM HEPES (N-2-hydroxyethylpipera-
zine-N’-2-ethanesulfonic acid) buffer, pH 8.0, at 10 °C.
The reaction was started by the addition of the syn-
thetic peptide Suc-Ala-Phe-Pro-Phe-p-nitroanilide. P-
nitroaniline chromophore release from the all-trans peptide
was monitored at 390 nm using the Infinite F500 (TECAN,
Swit).
CLP model and anti-CsCyPAs treatment
Ethical approval
All animal experiments in this paper were performed in
strict accordance with the Guide for the Care and Use of
Laboratory Animals of Sun Yat-sen University (Permit
Numbers: SCXK (Guangdong) 2009–0011). 220 KM male
mice (5–6 weeks of age and weighing 20-22 g) were
purchased from the Experimental Animal Center of Sun
Yat-sen University (Guangzhou, China) housed in a
temperature controlled, light-cycle room in animal fa-
cilities, with unlimited food and water.
Sepsis was induced in the mice model by CLP [23].
Twenty mice were selected randomly from the total ani-
mals as a sham-surgery group. The other two hundred
were randomly divided to two groups: <1 > The sham
group skipped the steps of cecal perforation, instead the
peritoneum was immediately closed after exposure of the
cecum. Normal saline (150 μl) was injected via the caudal
vein 6 h after surgery. <2 > CLP control group were
injected with 150 μl of normal saline via caudal vein
6 h after CLP surgery. < 3 > CLP treatment group were
injected with 150 μl of normal saline including 50 mg/kg
of purified antibodies. Mice in each group were divided
equally into five subgroups, which were sacrificed at 6, 12,
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24, 48 and 72 h respectively after surgery. There were four
mice in each sham surgery subgroup, twenty in each CLP
treatment subgroup and twenty in each CLP control
group. In each subgroup, survival mice were anesthetized
with diethyl ether, then blood collected into anticoagulant
and coagulant tubes through the eyeball and the mesen-
tery and lungs separated. The detection of survival rate
was presented in the 72 h subgroup.
Measured cytokine and CyPA in serum
Blood samples in each subgroup collected in coagulant
tubes (B&D, USA) were clotted for two hours at room
temperature before centrifugation for 15 min at 1000xg.
Serum was removed and stored samples at −80 °C.
MuCyPA were measured using a mouse cyclophilin A
ELISA Kit (CUSABIO, USA). TNF-α, IL-6, IL-1β, IL-4,
IL-10 and IFN-γ were determined by the corresponding
ELISA Kit (R&D, USA) according to the manufacturer’s
instructions. All samples were measured at OD450nm in a
Sunrise Absorbance reader (TECAN, Swit).
Pathological observation of lung and mesentery tissues
The mesentery and lung tissues were fixed in 10 % for-
maldehyde for 24 h and then embedded in paraffin.
Subsequently, the paraffin-embedded samples were cut
into 5 μm thick sections and stained with hematoxylin-
eosin. All samples were photographed and examined
immediately by Leica DM Microscopes (DM 2500B,
Germany, ×400).
Blood coagulation indicator
Blood samples in each subgroup collected by anticoagu-
lant tubes (Improve Medical, Guangzhou, China) were
texted within four hours. Prothrombin time (PT), acti-
vated partial thromboplastin time (aPTT) and fibrinogen
were detected in an automated coagulometer (Sysmex
CS2000i; Fuji, Japan). Platelet count was performed
using an automatic blood cell counter (Sysmex XS1000i;
Fuji, Japan). D-dimer was detected by D2D ELISA Kit
(R&D Systems, USA).
Vascular endothelial cells isolation, culture and treatment
The isolation of ECs from murine aorta was described
by Mika Kobayashi in 2005 [24]. Briefly, the aorta of KM
mice was dissected out from the aortic arch to the ab-
dominal aorta, and the connective tissues removed
under a stereoscopic microscope. ECs were isolated
from aorta by collagenase type II solution (2 mg/ml,
Fig 1 Alignment of CyPA Deduced Amino Acid Sequence from C.sinensis and Other Species. Letters with asterisk: site of forming disulfide bond.
Letters with frame: PPIase catalytic area
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dissolved in serum-free DMEM) for 45 min at 37 °C,
then, seeded into 96-well plates at 5,000 cells per 100 μl
for each well with endothelial cell phenol red free culture
medium (Sciencell, USA).
Different concentrations of rMuCyPA and anti-CsCyPAs
were co-cultured with ECs for 72 h before being measured
by Cells Counting Kit-8 (CCK-8) (Beyotime, Jiangsu, China)
according to the manufacturer’s instructions. Each well was
incubated with 10 μl of CCK-8 solution at 37 °C for 2 h
and measured at OD450nm in a Sunrise Absorbance reader
(TECAN, Swit). Each experiment was repeated three times.
Statistical analysis
Date was reported as the mean ± SD. All statistical analysis
was performed using Prism 5.0 (GraphPad Software,
USA). A significance level of 0.05 was considered to be
significant for all calculations.
Results
Homology analysis
The amino acid sequences of CsCyPA (AFI24615.1),
SjCyPA (ACU78101.1), MuCyPA (NP_032933.1) and
HsCyPA (AAI37059.1) were downloaded from Genebank
(http://www.ncbi.nlm.nih.gov/nuccore/). The identities of
amino acid sequence between CsCyPA and the other three
were 66 %, 74 % and 74 % respectively. The putative
PPIase catalytic area was identified by Motif Scan (http://
myhits.isb-sib.ch/cgi-bin/motif_scan). The identities of
amino acid sequence in catalytic area between CsCyPA
and the other three were ordinal 92 %, 83 % and 83 %
respectively. Sequence comparisons are shown in Fig 1.
Immunoreactivity between rCyPA and anti-CsCyPAs
Western blot analysis demonstrated that rCsCyPA, rSjCyPA,
rMuCyPA and rHsCyPA could be recognized by anti-
CsCyPAs, whilst not reacting with PBS in Fig 2. The re-
sults indicated that rCyPA of these species shared similar
immunoreactivity with anti-CsCyPAs.
Enzyme characteristics and inhibition experiments
Comparing 0 μg rMuCyPA reaction system (control group),
1 μg rMuCyPA reaction system and 10 μg rMuCyPA reac-
tion system, rMuCyPA showed dose-dependent improve-
ment on reaction rate in Fig 3. This result indicated that
recombinant MuCyPA possesses PPIase activity. To investi-
gate the ability of antibodies to inhibit enzymatic activity,
Fig 3 rMuCyPA Enzymatic Characteristics and Inhibition by Anti-CsCyPAs
Fig 2 Western Blot Detected Immunoreactivity between Recombinant CyPA Protein and Anti-CsCyPAs. a (1, 2, 3, 4) rCsCyPA, rSjCyPA, rMusCyPA
and rHsCyPA respectively probed with anti-CsCyPAs. b (1, 2, 3, 4) rCsCyPA, rSjCyPA, rMusCyPA and rHsCyPA respectively probed with PBS
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we co-cultured 1 μg or 10 μg antibodies with 10 μg rMu-
CyPA for 1 h and then continued the reaction. Comparing
10 μg rMuCyPA reaction system, 10 μg rMuCyPA with
1 μg antibodies reaction system and 10 μg rMuCyPA with
10 μg antibodies reaction system, antibodies showed signifi-
cant dose-dependent inhibition.
Survival rates
The survival rates were analyzed 72 h after the CLP
surgery. As is shown in Fig 4, the survival rate of Sham-
surgery group was 100 %. Two of the twenty mice left in
the CLP control 72 h subgroup, a survival rate of 10 %.
Nine of the twenty mice left in CLP treatment 72 h
subgroup, with a survival rate of 45 %. A statistically
significant difference between the CLP control group
and the CLP treatment group was observed (p < 0.05).
CyPA level in serum
Serum samples were collected from both the sham-
surgery group and the CLP control group. MuCyPA in
the CLP control group was statistically higher compared
with the sham group at 6, 12, 24 and 48 h (p < 0.05).
There was no significant difference at 72 h (p > 0.05). In
the CLP group, the CyPA level reached a climax at 6 h
followed by a time-dependent decrease in Fig 5.
Cytokine levels in serum
Cytokines which promoted inflammation like TNF-α,
IL-6 and adjusted inflammation like IL-4, IL-10 and
IFN-γ were chosen to represent the systematic inflam-
mation level. Administration of antibodies significantly
reduced the levels of TNF-α, IL-6 and IL-1β in serum
compared with CLP control mice (Fig 6a, b, c) at 12 h
and 24 h after CLP. Adjustment Cytokine had no statis-
tical meaning (Fig 6d, e, f ).
Histology of lung and mesentery tissues
H&E staining of the lung and mesentery of both the
CLP control group and the CLP treatment group were
shown in Fig 7. Lung tissue specimens in the CLP con-
trol group presented apparent thrombus at 12 h, and were
characterized by leukocyte influx, edema, hemorrhage,
wall thickening and alveolar consolidation at 48 h and
72 h (Fig.7a). In contrast, lung tissue in the CLP treatment
group presented apparent thrombus at 24 h, and dem-
onstrated leukocyte influx and edema without obvious
hemorrhage and alveolar consolidation at 48 h and
72 h (Fig. 7b). Significantly, comparing lung tissue at
48 h and 72 h, pathological change seemed ameliorated
in the CLP treatment group, while deteriorated in CLP
control group.
Compared with the CLP treatment groups, the mesen-
tery tissue in the CLP control group demonstrated more
serious inflammatory reaction. Tons of inflammatory
emigrated from vessel at 6 h. The boosting of cytolysis,
fusiform cells and intercellular substance led to diffuse
mesentery fibrosis at 72 h after surgery (Fig. 7c). In the
CLP treatment group, inflammation was limited and some
normal fat cells could still be observed at 72 h (Fig. 7d).
Fig 5 Detection of the Serum Level of CyPA in CLP and the Sham
Group. *P < 0.05 versus sham-surgery group; **P < 0.01 versus
sham-surgery group; ***P < 0.001 versus sham-surgery group
Fig 4 Survival Rates of Mice after CLP
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Effects of antibodies on blood coagulation indicator
As the laboratory diagnosis of diffuse intracellular co-
agulation (DIC) in the mice was defined by Minna JD
[25], the CLP model successfully induced DIC, as the
changes of blood markers were shown in Fig 8. Compared
with the sham group, the platelet count, fibrinogen con-
centration, PT, aPTT and D-dimer in the CLP control
group began to change significantly at 6 h post-CLP.
Comparing the CLP control group with the CLP treat-
ment group, there were significant differences on the indi-
cators including PT, aPTT, D-dimer and platelet count.
Furthermore, antibodies in mice obviously ameliorated
these four indicators at 48 h and at 72 h after the surgery.
Although there was no significant difference in fibrinogen
concentration, the significant changes of other indicators
showed strong evidences for the efficacy.
Fig 6 Change of Serum Cytokines in Mice after CLP. a TNF-α concentration in mice serum; b IL-6 concentration in mice serum; c IL-1βconcentra-
tion in mice serum; d IL-4 concentration in mice serum; e IL-10 concentration in mice serum; f IFN-γ concentration in mice serum; *P < 0.05 versus
CLP treatment group; **P < 0.01 versus CLP treatment group; ***P < 0.001 versus CLP treatment group
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Viability of ECs with MuCyPA and anti-CsCyPAs
by CCK-8 assays
To evaluate the viability of ECs after being co-cultured
with rMuCyPA, ECs were incubated in 0 μg (control),
0.1 μg, 1 μg and 10 μg MuCyPA for 24 h, and cell viability
was measured using the CCK-8 assays in Fig 9. Compared
with the control group, the viability of ECs exposed to
rMuCyPA showed a dose-dependent decrease. In the
inhibition test, 0.1 μg, 1 μg and 10 μg antibodies were
co-cultured with 10 μg MuCyPA for 1 h before reaction.
Compared with 10 μg MuCyPA group, the result showed
significant increase on the percentage of cells in the 1 μg
and 10 μg antibody groups in a dose-dependent manner
(p < 0.05). There was no significant difference between
10 μg MuCyPA group and 0.1 μg antibodies group
(p > 0.05).
Discussion
In this study, we found that the blood level of MuCyPA
increased in the development process of sepsis induced
by CLP surgery. Anti-CsCyPAs approach had a beneficial
effect on the survival rate of CLP mice and obviously
improved the observational indicators including blood
coagulation, lung and mesentery pathology and cytokine
levels in serum.
In 1992, Barbara et al. [9], found that lipopolysaccharide-
activated macrophages could secrete CyPA as a proinflam-
matory factor, the role of which in the inflammatory
disease was evaluated in following studies. It has been
found that CyPA significantly increased in the development
process of infection in a couple of studies. For example, in
2007, Dear et al., found that CyPA highly increased in the
liver after CLP [26]. Huang et al., reported that CyPA
expression was modulated in peripheral lymphocytes from
Pseudomonas aeruginosa induced sepsis [27] and Staphylo-
coccus aureus invasion [28]. Similarly, in our study, the
MuCyPA in serum, which might originate from the cells re-
ceiving inflammatory stimuli increased in abundance and
reached the climax at 6 h in Fig 5.
The mechanism of CyPA working as a proinflammatory
factor unequivocally depended on the combination with
CD147 receptor [11]. CD147, a single transmembrane
glycoprotein, is widely expressed on the cell surface which
can be expressed in all of the white blood cells, platelets
and endothelial cells in most normal tissues in weak or no
expression [29]. The proline 180 and glycine 181 residues
Fig 7 Histological Changes in Lung and Mesentery Tissues (hematoxylin-eosin; ×400). a, c lung and mesentery tissues of the CLP control group;
b, d lung and mesentery tissues of the CLP treatment group. Black arrow: thrombus; Red arrow: hemorrhage; Pink arrow: alveolar consolidation;
Yellow arrow: leukocyte aggregation; Gray arrow: alveolar wall thickening; Green arrow: inflammatory emigration; Blue arrow: mesentery fibrosis;
Orange arrow: normal fat cells
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in the extracellular domain of CD147 were critical for sig-
naling and chemotactic activities mediated by CD147
which could be accomplished by the PPIase activity of
CyPA [30]. The activated CD147 could transfer informa-
tion into cells, leading to chemotaxis, release of factor and
apoptosis of ECs which all induced deterioration of
the sepsis. Significantly, the expression of CD147 in
membrane was obviously increased in sepsis as was
CyPA. Furthermore, in 1997, Tegeder et al. reported
that CyPA PPIase activity was significantly higher in
patients with severe sepsis compared with healthy subjects.
In addition, elevated PPIase activity was associated with
high mortality [31].
In this study, anti-CsCyPAs could recognize and cross-
react with MuCyPA and effectively inhibit the PPIase
enzymic activity as the obvious identity of CyPA amino
acid sequence in different species, which may in turn
induce inhibition on the activity of CD147. Comparing
the CLP control group and the CLP treatment group
in Figs 6 and 7, antibodies approach had a significantly
favorable effect on the improvement of inflammation.
The proinflammatory cytokines including IL-6, IL-1β
and TNF-α were obviously lower compared with the
control group, while anti-inflammatory cytokines in-
cluding IL-10, IL-4 and IFN-γ presented no significant
difference between the two groups. The level of CyPA
increased at an early stage and followed by a drop to
the normal in 72 h, which suggested that CyPA plays a
primary role in the SIRS stage of sepsis, but is not signifi-
cantly involved with the compensatory anti-inflammatory
response syndrome (CARS) stage of sepsis. This reaction
might alleviate the systematic inflammatory reaction
and reduce the possibility of SIRS. Meanwhile, CyPA also
serves as a key determinant for TNF-α inducing ECs
apoptosis, which could also increase vascular permeability
and induce hypovolemic shock [11]. Therefore, the protec-
tion on ECs might be the main reason behind the in-
creased survival rate in the early stage. DIC is a common
complication of sepsis, and is associated with a poor prog-
nosis. The blood coagulation indicator in the treatment
Fig 8 Blood Markers of DIC in CLP Treatment, CLP Control and the Sham Groups
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group also showed a favorable progress after 24 h. Finally,
the immediate outcome of survival rate adequately proved
the efficacy of anti-CsCyPAs on sepsis.
There were three limitations of this study that warrant
notice. Firstly, the efficacy of antibodies might correlate
with the combination of antigen and antibodies that in-
hibit CyPA from combining with CD147. This mechanism
might play an important role as inhibition of enzyme.
Secondly, no in vivo experiment on the effect of antibodies
was carried out. It was found to be impossible to separate
pure mouse peritoneal macrophage due to the open
wound and persistent infection in abdomen after review-
ing many studies. Finally, anti-CyPA antibodies had been
verified to increase in some autoimmune diseases like
rheumatoid arthritis, systemic lupus, erythematosus and
so on, thus the safety of this “parasite medication” should
be further verified in further studies.
Conclusion
Anti-CsCyPA antibodies had a verified beneficial effect
on sepsis induced by CLP surgery by inhibiting the
PPIase activity. The indicators of pathology, cytokines,
blood coagulation indicator and survival rate all gener-
ally improved. As far as its safety is concerned, the pre-
ventative injection of CsCyPA might be controversial,
but anti-CsCyPAs as an alternative treating approach for
acute sepsis patients may be considerable.
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